BEIJING--June 8, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--China has authorized five companies for COVID-19 vaccine production: Sinopharm Beijing Institute, SinoVac, CanSinoBIO, Sinopharm Wuhan Institute and Anhui Zhifei Longcom. Industrial Info is tracking five active COVID-19 vaccine projects, worth $698 million in China, two of which will kick off in the second half of this year.
(All Fields Required)
Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.
×